Fifth Lane Capital »

Mirati Therapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 20k 58.75

More positions owned by Fifth Lane Capital

stock
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dish Network Corporation Cl A
ImmunoGen
Home Depot (HD)
Rpt Realty Sh Ben Int
Iron Horse Acquisitions Corp Unit 10/15/2028 (IROHU)
Mirati Therapeutics
Brookfield Renewable Partner Partnership Unit (BEP)
Evergy (EVRG)
Flex Ord (FLEX)
Chevron Corporation (CVX)
Wec Energy Group (WEC)
Seritage Growth Pptys Cl A (SRG)
Gracell Biotechnologies Sponsored Ads

View all positions for Fifth Lane Capital

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics